Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × acalabrutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 17 Lymphoma, Mantle-Cell 8 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Hairy Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hodgkin Disease 1 Glioblastoma 1 DLBCL 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Anemia, Hemolytic, Autoimmune 1

Interventions

Gemcitabine 141 Fluorouracil 41 Capecitabine 39 130-nm albumin-bound paclitaxel 39 Oxaliplatin 37 Albumin-Bound Paclitaxel 35 Leucovorin 31 Erlotinib Hydrochloride 29 Radiotherapy 20 Irinotecan 20 Bevacizumab 19 pembrolizumab 18 Radiosurgery 16 Docetaxel 16 Cyclophosphamide 15 Taxes 11 Cisplatin 11 Cetuximab 11 folfirinox 9 Nivolumab 9 Ipilimumab 7 Standard of Care 6 Radiation 6 spartalizumab 5 durvalumab 5 dehydroftorafur 5 Surgical Procedures, Operative 5 Paclitaxel 5 Hydroxychloroquine 5 Ascorbic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02362048 2019-10-01

KEYNOTE144

Acerta Pharma BV

Phase 2 Completed

77 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡